TITAN PHARMACEUTICALS INC — Director's Dealing 2007

May 21, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (AMEX - TTP)
CIK: 0000910267
Period of Report: 2007-05-17

Reporting Person: BHONSLE SUNIL (Director, Executive VP and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-05-17	Common Stock	P	1100	$2.00	Acquired	60500	Direct
2007-05-17	Common Stock	P	5000	$2.01	Acquired	65500	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	60894	Indirect

Footnotes

F1: Does not include 10,000 shares of common stock beneficially owned by the reporting person's adult son.

F2: The reporting person is the trustee of a family trust owning the indicated shares.